ConductScience.org, home

Paper34175366

Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.

Hasanzadeh A and 8 others. J Control Release, 2021. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies. Papers, record 34175366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34175366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies.
PubMed
Journal
J Control Release
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.12
iCite
Revised in PubMed
2024-09-26
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hasanzadeh AAkbar
2Alamdaran MMasoomeh
3Ahmadi SSepideh
4Nourizadeh HHelena
5Bagherzadeh MAMohammad Aref
6Mofazzal Jahromi MAMirza Ali
7Simon PPerikles
8Karimi MMahdi
9Hamblin MRMichael R

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
Humans
Immunization
Nanotechnology
Pandemics
SARS-CoV-2

References237

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132788923Stimulus-Responsive Sequential Release Systems for Drug and Gene Delivery.Nano Today2020https://conductscience.org/library/papers/32788923PubMed
218704954Vaccine adjuvants: current challenges and future approaches.J Pharm Sci2009https://conductscience.org/library/papers/18704954PubMed
332145190Liver injury in COVID-19: management and challenges.Lancet Gastroenterol Hepatol2020https://conductscience.org/library/papers/32145190PubMed
432313544Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus.Adv Funct Mater2019https://conductscience.org/library/papers/32313544PubMed
528782570Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing.Adv Drug Deliv Rev2018https://conductscience.org/library/papers/28782570PubMed
628177606Graphene-Based "Hot Plate" for the Capture and Destruction of the Herpes Simplex Virus Type 1.Bioconjug Chem2017https://conductscience.org/library/papers/28177606PubMed
732439197COVID-19 and Multiorgan Response.Curr Probl Cardiol2020https://conductscience.org/library/papers/32439197PubMed
820198909[Management of side effects during antiviral therapy].Acta Med Croatica2009https://conductscience.org/library/papers/20198909PubMed
930474052Streptavidin-conjugated gold nanoclusters as ultrasensitive fluorescent sensors for early diagnosis of HIV infection.Sci Adv2018https://conductscience.org/library/papers/30474052PubMed
1030030950Antiviral activity of Ribavirin nano-particles against measles virus.Cell Mol Biol (Noisy-le-grand)2018https://conductscience.org/library/papers/30030950PubMed
1131995857Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.N Engl J Med2020https://conductscience.org/library/papers/31995857PubMed
1225335768Development of biodegradable nanoparticles for liver-specific ribavirin delivery.J Pharm Sci2014https://conductscience.org/library/papers/25335768PubMed
1332401715Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.Lancet2020https://conductscience.org/library/papers/32401715PubMed
1432657566A Surface Coating that Rapidly Inactivates SARS-CoV-2.ACS Appl Mater Interfaces2020https://conductscience.org/library/papers/32657566PubMed
1533318701Arab nations first to approve Chinese COVID vaccine - despite lack of public data.Nature2020https://conductscience.org/library/papers/33318701PubMed
1627853344Mitochondrial Reactive Oxygen Species and Photodynamic Therapy.Laser Ther2016https://conductscience.org/library/papers/27853344PubMed
1733306989Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.Lancet2021https://conductscience.org/library/papers/33306989PubMed
1820845061Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme.J Neurooncol2011https://conductscience.org/library/papers/20845061PubMed
1922831552Investigation of quaternary ammonium silane-coated sand filter for the removal of bacteria and viruses from drinking water.J Appl Microbiol2012https://conductscience.org/library/papers/22831552PubMed
2032660339Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review.Otolaryngol Head Neck Surg2020https://conductscience.org/library/papers/32660339PubMed

See all 237 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
41359142Nanotechnology in COVID-19 prevention, diagnosis, and treatment: a comprehensive review.Discov Nano2025https://conductscience.org/library/papers/41359142PubMed
40213131Bioenergy-Based Closed-Loop Medical Systems for the Integration of Treatment, Monitoring, and Feedback.Small Sci2023https://conductscience.org/library/papers/40213131PubMed
38076059Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19.Heliyon2023https://conductscience.org/library/papers/38076059PubMed
37161688The Role of Pro-Inflammatory Mediator Interleukin-32 in Osteoclast Differentiation.Turk J Pharm Sci2023https://conductscience.org/library/papers/37161688PubMed
36721714Graphene oxide and flavonoids as potential inhibitors of the spike protein of SARS-CoV-2 variants and interaction between ligands: a parallel study of molecular docking and DFT.Struct Chem2023https://conductscience.org/library/papers/36721714PubMed
36507266Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36507266PubMed
36312553Advances in the use of nanomaterials for nucleic acid detection in point-of-care testing devices: A review.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36312553PubMed
35982065Considering epitopes conservity in targeting SARS-CoV-2 mutations in variants: a novel immunoinformatics approach to vaccine design.Sci Rep2022https://conductscience.org/library/papers/35982065PubMed
35910658A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19.Front Microbiol2022https://conductscience.org/library/papers/35910658PubMed
35567581Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022?J Glob Health2022https://conductscience.org/library/papers/35567581PubMed
35269270Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment.Nanomaterials (Basel)2022https://conductscience.org/library/papers/35269270PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34175366

GET https://conductscience.org/api/papers/v1/34175366/references?page=2